| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10307466 | Schizophrenia Research | 2013 | 6 Pages |
Abstract
Differences in premorbid functioning may explain apparent differences in neurocognitive function between schizophrenia spectrum patients using cannabis or not. The findings suggest that illness-related traits present early in life can affect both later cannabis use and neurocognition, probably by complex mechanisms.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
P. Andreas Ringen, Ingrid Melle, Akiah O. Berg, Ingrid Agartz, Olav Spigset, Carmen Simonsen, Kjetil Sundet, Ole A. Andreassen,